Switchgear companies play a critical role in India’s energy transition, electrification push, and infrastructure upgrades, but it's important to keep in mind the risks.

BioNTech’s ASCO 2025 abstracts showcase advances in oncology, from bispecific antibodies to mRNA immunotherapies. Annemarie Hanekamp shares insights on pipeline progress—watch now!

During the 2025 ASCO Annual Meeting, key updates were shared across all of oncology, including across lung cancer care. These updates are important for patients to learn more about, as these new data ...

Uzbekistan is set to upgrade two major substations in Tashkent through a new contract with a Chinese company. The project ...

Updates in metastatic NSCLC from ASCO 2025 include data from TROPION-Lung02 on Dato-DXd, KRYSTAL-7 on first-line adagrasib, and zipalertinib from REZILIENT1, presented by Dr Jonathan Goldman.

ASCO 2025 may be over, but the insights are just beginning. This “Spotlight On” page is your hub for ongoing post-event coverage, including expert interviews, key takeaways, and video content ...

In this episode, recorded live at the 2025 ASCO annual meeting, host Shikha Jain, MD, speaks with Sonali Smith, MD, about the power of mentorship and advocacy, preserving the academic mission of ...

Leaders in oncology share why the American Society of Clinical Oncology (ASCO) meeting remains a top global gathering for breakthroughs, networking, and lifelong learning.

RMC Switchgears, operating in the Electric Equipment - Switchgear/Circuit Breaker sector and classified as a Smallcap on the BSE, currently has its share price at ₹771.75.

Brian P. Mulherin, MD, shares his key takeaways from the 2025 ASCO Annual Meeting, highlighting significant advancements in SCLC and the challenge of information overload at large conferences.